CTHRC1 and PD‑1/PD‑L1 expression predicts tumor recurrence in prostate cancer
Open Access
- 19 September 2019
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 20 (5), 4244-4252
- https://doi.org/10.3892/mmr.2019.10690
Abstract
Collagen triple helix repeat containing 1 (CTHRC1) is a gene that has been associated with tumor progression in human prostate cancer (PC). The tumor immune microenvironment has been linked with disease outcome in PC. In the present study, the correlation between CTHRC1 with PC recurrence and the tumor immunological microenvironment was investigated. Using the data supplied by the Tumor Immune Estimation Resource (TIMER), the expression of CTHRC1, programmed cell death protein 1 (PD‑1), and programmed cell death 1 ligand 1 (PD‑L1) were analyzed. Immunohistochemical staining of CTHRC1, PD‑1 and PD‑L1 was performed using a tissue microarray construction of prostate adenocarcinoma (PRAD) specimens. In PRAD, an association was reported between the CTHRC1 expression and the disease free survival (DFS) rate (P=0.022). Overexpression of CTHRC1 was correlated with increased levels of PD‑1 (R=0.272, P=0.021) and PD‑L1 (R=0.298, P=0.016), elevated levels of infiltrating B cells (P=9.51e‑11), CD4+ cells (P=1.51e‑11), macrophages (P=8.25e‑5), neutrophils (P=2.17e‑9) and dendritic cells (P=3.13e‑13). Bioinformatics analysis revealed that CTHRC1 was correlated with the expression levels of matrix metalloproteinase‑9, mucin 1 and solute carrier organic anion transporter family member 2B1 genes, which exert an influence in PRAD. The occurrence of this condition is most likely to be associated with regulation of the tumor microenvironment. Taken together, we demonstrated that the prognosis and immunity of PC are closely linked to CTHRC1 upregulation. Furthermore, these results suggest that the immune function of PC may be suppressed by CTHRC1‑targeting therapy.Keywords
This publication has 49 references indexed in Scilit:
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 TherapyClinical Cancer Research, 2014
- Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motilityInternational Journal of Oncology, 2014
- Cthrc1 overexpression is an independent prognostic marker in gastric cancerHuman Pathology, 2014
- CTHRC1 Acts as a Prognostic Factor and Promotes Invasiveness of Gastrointestinal Stromal Tumors by Activating Wnt/PCP-Rho SignalingNeoplasia, 2014
- Prognostic Gleason grade grouping: data based on the modified Gleason scoring systemBJU International, 2013
- MUC1‐C oncoprotein confers androgen‐independent growth of human prostate cancer cellsThe Prostate, 2012
- Regulatory T cells in the bone marrow microenvironment in patients with prostate cancerOncoImmunology, 2012
- Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox TherapyCancers, 2011
- Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid CancersClinical Cancer Research, 2006
- Hypermethylation of GSTP1, CD44, and E‐cadherin genes in prostate cancer among US Blacks and WhitesThe Prostate, 2003